Evidence for and Against Green Tea and Turmeric in the Management of Chronic Lymphocytic Leukemia.

Erin Bange, Colleen Timlin, Charlene Kabel, Jakub Svoboda, Lindsey Roeker, Anthony R Mato

Journal: Clinical lymphoma, myeloma & leukemia 2019;18(10):e421-e426

PMID: 30007569

Free Full Text on PubMed Central View on PubMed

Abstract

Complementary and alternative medicine (CAM) is a diverse group of medical and health care systems, practices, and products that are not generally considered part of conventional medicine. Chronic lymphocytic leukemia (CLL) is the most common leukemia diagnosed in the western hemisphere, and 16.5% to 66% of patients have reported using CAM. Most patients use spiritual/mind-body techniques and high doses of vitamins and herbs (most commonly polyphenols, including teas). We have reviewed the reported data on green tea and turmeric use in CLL patients.

Address: Center for CLL, Abramson Cancer Center, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA.; CLL Program, Leukemia Service, Section of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY.; CLL Program, Leukemia Service, Section of Hematologic Oncology, Memorial Sloan Kettering Cancer Center, New York, NY. Electronic address: [email protected].

DOI: 10.1016/j.clml.2018.06.021

Link outs

Free resources

Full Text Sources:

Other Literature Sources:

https://scite.ai/reports/30007569

Subscription / membership required

Full Text Sources:

MeSH Terms: Antineoplastic Agents, Curcuma, Disease Management, Herb-Drug Interactions, Humans, Leukemia, Lymphocytic, Chronic, B-Cell, Tea